Nova-sTAR PIONEER-JP-Panel Interview of ONcology practice with Experience of TAR-200 in Japan

Nova-sTAR PIONEER-JP-Panel Interview of ONcology practice with Experience of TAR-200 in Japan - Nova-sTAR PIONEER-JP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060775

Enrollment

Registered

2026-02-27

Start date

2026-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Physicians who meet the following criteria: 1.Had experience of treatment with TAR-200 in HR-NMIBC and/or MIBC patients in clinical trials. 2.Provided consent to participate in the interview and/or roundtable discussion.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Qualitative data describing physicians' experiences with TAR-200 insertion, removal, and patient care (e.g., AE monitoring, treatment schedule, patient education, patient follow-up).	—

Secondary

Measure	Time frame
Qualitative data identifying barriers, proposed solutions, opportunities for improvement in medical adoption of TAR-200, and anticipated evolution of the health care model.	—

Countries

Japan

Contacts

Public ContactHikaru Onishi

INTAGE Healthcare Inc. Value & Access Department

onishi.46072@intage.com03-5294-8393

Outcome results